{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T04:08:02Z","timestamp":1751083682744,"version":"3.41.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.gofs.2025.03.010","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T14:21:59Z","timestamp":1743690119000},"page":"341-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pr\u00e9vention secondaire de l\u2019infection foetale \u00e0 cytom\u00e9galovirus par l\u2019administration de valaciclovir dans les primo-infections maternelles p\u00e9riconceptionnelles et du premier trimestre de la grossesse"],"prefix":"10.1016","volume":"53","author":[{"given":"Christos","family":"Chatzakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Bourgon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Leruez-Ville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Ville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gofs.2025.03.010_bib0145","unstructured":"Pr\u00e9vention de l\u2019infection \u00e0 cytom\u00e9galovirus chez la femme enceinte et le nouveau-n\u00e9 Rapport. Haut Conseil de la Sante Publique. 2018."},{"issue":"4","key":"10.1016\/j.gofs.2025.03.010_bib0150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev Med Virol"},{"issue":"6","key":"10.1016\/j.gofs.2025.03.010_bib0155","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ajog.2020.05.038","article-title":"Timing of primary maternal cytomegalovirus infection and rates of vertical transmission and fetal consequences","volume":"223","author":"Chatzakis","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"10253","key":"10.1016\/j.gofs.2025.03.010_bib0160","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0140-6736(20)31868-7","article-title":"Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial","volume":"396","author":"Shahar-Nissan","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.gofs.2025.03.010_bib0165","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/uog.23685","article-title":"Secondary prevention of congenital cytomegalovirus infection with valaciclovir following maternal primary infection in early pregnancy","volume":"58","author":"Faure-Bardon","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2025.03.010_bib0170","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/uog.26039","article-title":"New data on efficacy of valaciclovir in secondary prevention of maternal\u2013fetal transmission of cytomegalovirus","volume":"61","author":"Egloff","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2025.03.010_bib0175","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ajog.2023.07.022","article-title":"The effect of valaciclovir on secondary prevention of congenital cytomegalovirus infection, following primary maternal infection acquired periconceptionally or in the first trimester of pregnancy. An individual patient data meta-analysis","volume":"230","author":"Chatzakis","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gofs.2025.03.010_bib0180","unstructured":"Cochrane Reviewers\u2019 Handbook, Version 5.1 Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Colllaboration, 2011. Available from www.cochrane-handbook.org."},{"key":"10.1016\/j.gofs.2025.03.010_bib0185","unstructured":"Risk of bias tools - RoB 2 tool. https:\/\/sites.google.com\/site\/riskofbiastool\/welcome\/rob-2-0-tool. Accessed February 18, 2019."},{"key":"10.1016\/j.gofs.2025.03.010_bib0190","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","author":"Sterne","year":"2016","journal-title":"BMJ"},{"year":"2021","series-title":"Individual Participant Data Meta-Analysis: A Handbook for Healthcare Research","author":"Riley","key":"10.1016\/j.gofs.2025.03.010_bib0195"},{"key":"10.1016\/j.gofs.2025.03.010_bib0200","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1063\/1.3295638","article-title":"Introduction To Monte Carlo Simulation","volume":"1204","author":"Harrison","year":"2010","journal-title":"AIP Conf Proc"},{"key":"10.1016\/j.gofs.2025.03.010_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6947-8-27","article-title":"Adapting a Markov Monte Carlo simulation model for forecasting the number of Coronary Artery Revascularisation Procedures in an era of rapidly changing technology and policy","volume":"8","author":"Mannan","year":"2008","journal-title":"BMC Medical Informatics and Decision Making"},{"issue":"10","key":"10.1016\/j.gofs.2025.03.010_bib0210","doi-asserted-by":"crossref","first-page":"101101","DOI":"10.1016\/j.ajogmf.2023.101101","article-title":"Treatment with valaciclovir during pregnancy for prevention of congenital cytomegalovirus infection: a real-life multicenter Italian observational study","volume":"5","author":"Zammarchi","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"3","key":"10.1016\/j.gofs.2025.03.010_bib0215","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/jrsm.1303","article-title":"A comparison of one-stage vs two-stage individual patient data meta-analysis methods: A simulation study","volume":"9","author":"Kontopantelis","year":"2018","journal-title":"Res Synth Methods"},{"issue":"4","key":"10.1016\/j.gofs.2025.03.010_bib0220","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/uog.26136","article-title":"Effectiveness and safety of prenatal valaciclovir for congenital cytomegalovirus infection: systematic review and meta-analysis","volume":"61","author":"D\u2019Antonio","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.gofs.2025.03.010_bib0225","unstructured":"Le Centre de R\u00e9f\u00e9rence sur les Agents T\u00e9ratog\u00e8nes. (2024, October 25). Valaciclovir\u2013Grossesse. Le CRAT. https:\/\/www.lecrat.fr\/8595\/."},{"issue":"4","key":"10.1016\/j.gofs.2025.03.010_bib0230","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/uog.24753","article-title":"Renal toxicity of high-dosage valaciclovir for secondary prevention of congenital cytomegalovirus infection: a dose regimen-related issue","volume":"58","author":"Ville","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.gofs.2025.03.010_bib0235","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. 2025. \u00c9valuation de la pertinence d\u2019un d\u00e9pistage syst\u00e9matique de l\u2019infection \u00e0 cytom\u00e9galovirus (CMV) au cours de la grossesse\u2013Feuille de route. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2025-01\/evaluation_de_la_pertinence_dun_depistage_systematique_de_linfection_a_cytomegalovirus_au_cours_de_la_grossesse_-_feuille_de.pdf."},{"key":"10.1016\/j.gofs.2025.03.010_bib0240","unstructured":"E\u03bb\u03bb\u03b7\u03bd\u03b9\u03ba\u03ae M\u03b1\u03b9\u025b\u03c5\u03c4\u03b9\u03ba\u03ae \u03ba\u03b1\u03b9 \u0393\u03c5\u03bd\u03b1\u03b9\u03ba\u03bf\u03bb\u03bf\u03b3\u03b9\u03ba\u03ae E\u03c4\u03b1\u03b9\u03c1\u025b\u03af\u03b1. 2025. K\u03b1\u03c4\u025b\u03c5\u03b8\u03c5\u03bd\u03c4\u03ae\u03c1\u03b9\u03b1 O\u03b4\u03b7\u03b3\u03af\u03b1 N\u03bf 71: \u03a0\u03c1\u03bf\u03b3\u025b\u03bd\u03bd\u03b7\u03c4\u03b9\u03ba\u03ae \u03c0\u03c1\u00f3\u03bb\u03b7\u03c8\u03b7 \u03ba\u03b1\u03b9 \u03b1\u03bd\u03c4\u03b9\u03bc\u025b\u03c4\u03ce\u03c0\u03b9\u03c3\u03b7 \u03c4\u03b7\u03b6 \u03bb\u03bf\u03af\u03bc\u03c9\u03be\u03b7\u03b6 \u03b1\u03c0\u00f3 \u03ba\u03c5\u03c4\u03c4\u03b1\u03c1\u03bf\u03bc\u025b\u03b3\u03b1\u03bb\u03bf\u03ca\u00f3 (CMV). https:\/\/hsog.gr\/wp-content\/uploads\/2025\/02\/KATEY\u0398YNTHPIA-O\u0394H\u0393IA-No-71-\u03a0PO\u0393ENNHTIKH-\u03a0PO\u039bH\u03a8H-KAI-ANTIMET\u03a9\u03a0I\u03a3H-TH\u03a3-\u039bOIM\u03a9\u039eH\u03a3-A\u03a0O-KYTTAPOME\u0393A\u039bOIO.pdf."},{"key":"10.1016\/j.gofs.2025.03.010_bib0245","unstructured":"Istituto Superiore di Sanit\u00e0. 2023. Gravidanza fisiologica. Prima parte. Sezione 1 - Informazioni alle donne in gravidanza. Sezione 2 - Screening delle infezioni in gravidanza. Linea guida 1\/2023 SNLG. https:\/\/www.iss.it\/documents\/20126\/9184367\/SNLG+1_2023+Gravidanza-fisiologica+Parte-1.pdf\/1b3c23be-4578-48f8-277a-88cf0a98de6c?t=1708700731145."},{"year":"1968","series-title":"Principles and Practice of Screening for Disease","author":"Wilson","key":"10.1016\/j.gofs.2025.03.010_bib0250"},{"key":"10.1016\/j.gofs.2025.03.010_bib0255","unstructured":"LOI n(2022-295 du 2 mars 2022 visant \u00e0 renforcer le droit \u00e0 l\u2019avortement [Law No. 2022-295 of March 2, 2022, aimed at strengthening abortion rights]. Journal Officiel de la R\u00e9publique Fran\u00e7aise, March 2, 2022. Retrieved from https:\/\/www.legifrance.gouv.fr."},{"key":"10.1016\/j.gofs.2025.03.010_bib0260","unstructured":"Code de la Sant\u00e9 Publique [Public Health Code], art. L. 2213-1 (Law No. 2001-588 of July 4, 2001). Retrieved from https:\/\/www.legifrance.gouv.fr."},{"key":"10.1016\/j.gofs.2025.03.010_bib0265","doi-asserted-by":"crossref","first-page":"100892","DOI":"10.1016\/j.lanepe.2024.100892","article-title":"Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)","volume":"40","author":"Leruez-Ville","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.gofs.2025.03.010_bib0270","unstructured":"Centre National de R\u00e9f\u00e9rence des herp\u00e8s virus. Universit\u00e9 de Limoges, www.unilim.fr\/cnr-herpesvirus\/. Accessed [10\/2024]."},{"key":"10.1016\/j.gofs.2025.03.010_bib0275","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/uog.26226","article-title":"Cost-effectiveness of screening and valaciclovir-based treatment strategies for first-trimester cytomegalovirus primary infection in pregnant women in France","author":"P\u00e9rillaud-Dubois","year":"2023","journal-title":"Ultrasound Obstet Gynecol 62.4"},{"issue":"2","key":"10.1016\/j.gofs.2025.03.010_bib0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/1471-0528.16966","article-title":"Leaning towards Cytomegalovirus serological screening in pregnancy to prevent congenital infection: a cost-effectiveness perspective","volume":"129","author":"Seror","year":"2022","journal-title":"BJOG: An International Journal of Obstetrics & Gynaecology"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718925000911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718925000911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T15:41:39Z","timestamp":1751038899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718925000911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":28,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2468718925000911"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2025.03.010","relation":{},"ISSN":["2468-7189"],"issn-type":[{"type":"print","value":"2468-7189"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pr\u00e9vention secondaire de l\u2019infection foetale \u00e0 cytom\u00e9galovirus par l\u2019administration de valaciclovir dans les primo-infections maternelles p\u00e9riconceptionnelles et du premier trimestre de la grossesse","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2025.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}